# Modafinil for Treatment of Fatigue in ALS Patients

> **NCT00614926** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 32 (actual)

## Conditions studied

- Fatigue

## Interventions

- **DRUG:** Modafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00614926
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614926, "Modafinil for Treatment of Fatigue in ALS Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00614926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*